Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by Mativ Holdings in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Mativ Holdings’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:35 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001000623-26-000067
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of products sold | 418.5 | 421.7 | 813.2 | 833.9 |
| Gross profit | 113.3 | 103.7 | 198.2 | 176.3 |
| Selling and general expense | 56.6 | 57.2 | 111.4 | 120.5 |
| Research and development expense | 4.9 | 6.7 | 10.4 | 13.0 |
| Intangible asset amortization expense | 15.8 | 15.9 | 31.8 | 31.3 |
| Total nonmanufacturing expenses | 77.3 | 79.8 | 153.6 | 164.8 |
| Goodwill impairment expense | — | — | — | 411.9 |
| Restructuring and other impairment expense | 0.7 | 3.8 | 2.0 | 10.1 |
Item 1. Financial Statements
FAQ
- What is Mativ Holdings's R&D?
- Mativ Holdings (MATV) reported R&D of $4.9M in Q2 2026.
- How has Mativ Holdings's R&D changed year-over-year?
- Mativ Holdings's R&D decreased by 26.9% year-over-year, from $6.7M to $4.9M.
- What is the long-term trend for Mativ Holdings's R&D?
- Over 3 years (2022 to 2025), Mativ Holdings's R&D has grown at a 1.5% compound annual growth rate (CAGR), from $22.6M to $23.6M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Mativ Holdings's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude